To further study the clinical significance of PTPRD and CNTNAP2 in diffuse gliomas with the current WHO tumor classification, we analyzed TCGA diffuse glioma data for chromosomal rearrangements, CNAs, DNA methylation, and RNA expression levels of these genes. This evidence concerns the gene CNTNAP2 and neoplasm.